Search Results - "Lees, Charlie W."
-
1
Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease
Published in Nature genetics (01-02-2017)“…Jeffrey Barrett, Carl Anderson and colleagues report the results of a large genome-wide association study of inflammatory bowel disease. They identify 25 new…”
Get full text
Journal Article -
2
IBD prevalence in Lothian, Scotland, derived by capture-recapture methodology
Published in Gut (01-11-2019)“…IBD prevalence is estimated to be rising, but no detailed, recent UK data are available. The last reported prevalence estimate in the UK was 0.40% in 2003. We…”
Get more information
Journal Article -
3
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic
Published in Gut (01-06-2020)“…The COVID-19 pandemic is putting unprecedented pressures on healthcare systems globally. Early insights have been made possible by rapid sharing of data from…”
Get more information
Journal Article -
4
The impact of different DNA extraction kits and laboratories upon the assessment of human gut microbiota composition by 16S rRNA gene sequencing
Published in PloS one (24-02-2014)“…Determining bacterial community structure in fecal samples through DNA sequencing is an important facet of intestinal health research. The impact of different…”
Get full text
Journal Article -
5
Exploring the genetic architecture of inflammatory bowel disease by whole-genome sequencing identifies association at ADCY7
Published in Nature genetics (01-02-2017)“…Carl Anderson, Jeffrey Barrett and colleagues use whole-genome sequencing and imputation to explore the genetic architecture of inflammatory bowel disease…”
Get full text
Journal Article -
6
Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility
Published in Nature genetics (01-07-2007)“…A genome-wide association scan in individuals with Crohn's disease by the Wellcome Trust Case Control Consortium detected strong association at four novel…”
Get full text
Journal Article -
7
The Impact of NOD2 Variants on Fecal Microbiota in Crohn's Disease and Controls Without Gastrointestinal Disease
Published in Inflammatory bowel diseases (16-02-2018)“…Abstract Background/Aims Current models of Crohn's disease (CD) describe an inappropriate immune response to gut microbiota in genetically susceptible…”
Get full text
Journal Article -
8
Modeling of Treatment Outcomes with Tofacitinib Maintenance Therapy in Patients with Ulcerative Colitis: A Post Hoc Analysis of Data from the OCTAVE Clinical Program
Published in Advances in therapy (01-10-2023)“…Introduction Tofacitinib is an oral small molecule Janus kinase inhibitor for the treatment of ulcerative colitis (UC). This post hoc analysis assessed whether…”
Get full text
Journal Article -
9
Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease
Published in Nature genetics (01-06-2008)“…We report results of a nonsynonymous SNP scan for ulcerative colitis and identify a previously unknown susceptibility locus at ECM1. We also show that several…”
Get full text
Journal Article -
10
Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities
Published in Gastroenterology (New York, N.Y. 1943) (01-04-2022)“…Inflammatory bowel disease is a progressive and debilitating condition. Early and effective treatment using a treat-to-target approach is key to improving…”
Get full text
Journal Article -
11
Non-serious adverse events in patients with ulcerative colitis receiving etrasimod: an analysis of the phase II OASIS and phase III ELEVATE UC 52 and ELEVATE UC 12 clinical trials
Published in Therapeutic advances in gastroenterology (01-01-2024)“…Background: Etrasimod is an oral, once-daily (QD), selective sphingosine 1-phosphate (S1P) 1,4,5 receptor modulator for the treatment of moderately to severely…”
Get full text
Journal Article -
12
-
13
Long-term outcomes and predictors of vedolizumab persistence in ulcerative colitis
Published in Therapeutic advances in gastroenterology (01-01-2024)“…Long-term vedolizumab (VDZ) outcomes in real-world cohorts have been largely limited to 1-year follow-up, with few bio-naïve patients or objective markers of…”
Get full text
Journal Article -
14
Bilateral lower limb weakness in acute severe ulcerative colitis
Published in The Lancet (British edition) (02-07-2016)“…An obese 49-year-old man with no medical history of note presented in August, 2014, with a 5-week history of bloody diarrhoea, anorexia, and unintentional…”
Get full text
Journal Article -
15
Prediction of early clinical response in patients receiving tofacitinib in the OCTAVE Induction 1 and 2 studies
Published in Therapeutic advances in gastroenterology (01-11-2021)“…Introduction: Tofacitinib is an oral, small molecule Janus kinase inhibitor for the treatment of ulcerative colitis (UC). Outcome prediction based on early…”
Get full text
Journal Article -
16
Environmental stimuli and gut inflammation via dysbiosis in mouse and man
Published in Nature reviews. Gastroenterology & hepatology (01-12-2020)“…A new study sheds further light on the interplay between environmental stimuli, the gut microbiota and intestinal inflammation. Identification of modifiable…”
Get full text
Journal Article -
17
Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD
Published in Gut (01-10-2021)“…Delayed second dose SARS-CoV-2 vaccination trades maximal effectiveness for a lower level of immunity across more of the population. We investigated whether…”
Get more information
Journal Article -
18
COVID-19 and IBD drugs: should we change anything at the moment?
Published in Gut (01-04-2021)Get more information
Journal Article -
19
Analysis of germline GLI1 variation implicates hedgehog signalling in the regulation of intestinal inflammatory pathways
Published in PLoS medicine (01-12-2008)“…Ulcerative colitis (UC) and Crohn's disease (CD) are polygenic chronic inflammatory bowel diseases (IBD) of high prevalence that are associated with…”
Get full text
Journal Article -
20
Association Between Level of Fecal Calprotectin and Progression of Crohn's Disease
Published in Clinical gastroenterology and hepatology (01-10-2019)“…Mucosal healing is associated with improved outcomes in patients with Crohn’s disease (CD), but assessment typically requires ileocolonoscopy. Calprotectin can…”
Get full text
Journal Article